Search Results 101-110 of 16391 for Huntington's+disease
The Genetics of Alzheimer's Disease and Endophenotypes Lab under Dr. Ertekin-Taner studies underlying genetic risk and protective factors involved in AD.
Endothelial dysfunction appears to be caused by both sleep disordered breathing and obesity. As endothelial dysfunction is among the first clinical marker that ...
Research in the Mayo Clinic Robert M. and Billie Kelley Pirnie Translational Polycystic Kidney Disease Center is leading to better treatments for PKD, ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
The purpose of this study is to collect blood samples for DNA analysis from patients clinically diagnosed with Alzheimers disease, Lewy Body disease, and ...
The purpose of the study is to examine the effect of different dosages of Exendin on glucose metabolism, glucagon and insulin secretion, and on insulin action.
Neurologists are working to uncover the risks, predictors, prevention, diagnostic tests and potential treatments for Alzheimer's disease, mild cognitive ...
About this study. The Parkinson Progression Marker Initiative (PPMI) is a study to assess progression of clinical features, digital outcomes, and imaging, ...
Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...
Dr. Nilüfer Ertekin-Taner discusses characteristics of neurodegenerative diseases and her research into the complex genetics of Alzheimer's at Mayo Clinic.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.